493 related articles for article (PubMed ID: 37792957)
1. Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH).
Wang S; Friedman SL
Sci Transl Med; 2023 Oct; 15(716):eadi0759. PubMed ID: 37792957
[TBL] [Abstract][Full Text] [Related]
2. Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction-associated steatohepatitis.
Steffani M; Geng Y; Pajvani UB; Schwabe RF
J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557494
[TBL] [Abstract][Full Text] [Related]
3. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module.
Bendixen SM; Jakobsgaard PR; Hansen D; Hejn KH; Terkelsen MK; Bjerre FA; Thulesen AP; Eriksen NG; Hallenborg P; Geng Y; Dam TV; Larsen FT; Wernberg CW; Vijayathurai J; Scott EAH; Marcher AB; Detlefsen S; Grøntved L; Dimke H; Berdeaux R; de Aguiar Vallim TQ; Olinga P; Lauridsen MM; Krag A; Blagoev B; Ravnskjaer K
J Hepatol; 2024 Mar; 80(3):467-481. PubMed ID: 37972658
[TBL] [Abstract][Full Text] [Related]
4. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a peripheral 5HT
Pagire HS; Pagire SH; Jeong BK; Choi WI; Oh CJ; Lim CW; Kim M; Yoon J; Kim SS; Bae MA; Jeon JH; Song S; Lee HJ; Lee EY; Goughnour PC; Kim D; Lee IK; Loomba R; Kim H; Ahn JH
Nat Commun; 2024 Jan; 15(1):645. PubMed ID: 38245505
[TBL] [Abstract][Full Text] [Related]
6. Can liquid biopsies for MASH help increase the penetration of metabolic surgery? A narrative review.
Castagneto-Gissey L; Bornstein SR; Mingrone G
Metabolism; 2024 Feb; 151():155721. PubMed ID: 37923007
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 (IL-13)-A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis.
Roeb E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629063
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma.
Wang H; Tsung A; Mishra L; Huang H
EBioMedicine; 2024 Mar; 101():105031. PubMed ID: 38401419
[TBL] [Abstract][Full Text] [Related]
9. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).
Gallego-Durán R; Albillos A; Ampuero J; Arechederra M; Bañares R; Blas-García A; Berná G; Caparrós E; Delgado TC; Falcón-Pérez JM; Francés R; Fernández-Barrena MG; Graupera I; Iruzubieta P; Nevzorova YA; Nogueiras R; Macías RIR; Martín F; Sabio G; Soriano G; Vaquero J; Cubero FJ; Gracia-Sancho J
Gastroenterol Hepatol; 2022 Nov; 45(9):724-734. PubMed ID: 35248669
[TBL] [Abstract][Full Text] [Related]
10. An update on the recent advances in antifibrotic therapy.
Tacke F; Weiskirchen R
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1143-1152. PubMed ID: 30261763
[TBL] [Abstract][Full Text] [Related]
11. Roles of immune dysregulation in MASLD.
Dong T; Li J; Liu Y; Zhou S; Wei X; Hua H; Tang K; Zhang X; Wang Y; Wu Z; Gao C; Zhang H
Biomed Pharmacother; 2024 Jan; 170():116069. PubMed ID: 38147736
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis.
Kunlayawutipong T; Apaijai N; Tepmalai K; Kongkarnka S; Leerapun A; Pinyopornpanish K; Soontornpun A; Chattipakorn SC; Chattipakorn N; Pinyopornpanish K
Heliyon; 2024 Mar; 10(6):e27557. PubMed ID: 38496899
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
[TBL] [Abstract][Full Text] [Related]
14. The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
Petta S; Targher G; Romeo S; Pajvani UB; Zheng MH; Aghemo A; Valenti LVC
Liver Int; 2024 Apr; ():. PubMed ID: 38578141
[TBL] [Abstract][Full Text] [Related]
15. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms in MASLD/MASH-related HCC.
Wang X; Zhang L; Dong B
Hepatology; 2024 Feb; ():. PubMed ID: 38349726
[TBL] [Abstract][Full Text] [Related]
17. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).
Subramanian P; Hampe J; Tacke F; Chavakis T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805998
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis antagonizing transcription factor-mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis-hepatocellular carcinoma.
Srinivas AN; Suresh D; Chidambaram SB; Santhekadur PK; Kumar DP
J Cell Physiol; 2024 Jan; 239(1):135-151. PubMed ID: 37942831
[TBL] [Abstract][Full Text] [Related]
19. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
[TBL] [Abstract][Full Text] [Related]
20. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study.
Kouvari M; Valenzuela-Vallejo L; Guatibonza-Garcia V; Polyzos SA; Deng Y; Kokkorakis M; Agraz M; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; George J; Mingrone G; Mantzoros CS
Metabolism; 2023 Oct; 147():155666. PubMed ID: 37527759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
